把三张表、经营指标、SEC / 巨潮 / 港交所原始财报、业绩材料和电话会放到同一条可核验时间线上。 披露事实、结构化补位值与派生指标分开标注，缺失逐字稿不会用摘要或模型生成内容补齐。
单季、累计、年度和资产负债表时点分开保存；每个数值都保留单位、申报日、表单、XBRL 概念或原始中文字段。
美股链接 SEC 法定申报和发行人 IR，A 股链接巨潮原始 PDF，港股链接港交所披露易原始年报与中报。分部、订单、产能和客户集中度只在有可核验披露时展示。
官方电话会入口与已授权逐字稿分开。没有合法取得的全文时只显示材料可用性，不生成或拼接虚假的逐字稿。
三张表会执行资产负债、毛利润、税前利润等勾稽检查；超出容差的记录保留原值并标记警告， 不会为了让公式“对上”而修改公司披露。
| 2026-06-30 |
| 3/3 |
| $307.91M |
| $80.83M |
| $296.67M |
| — |
| 27.5% |
| 135 |
| 尚无授权文本 |
| APD Air Products & Chemicals, Inc. | 2026-06-30 | 3/3 | $3.16B | -$1.44B | -$44.9M | 32.8% | -66.3% | 86 | 尚无授权文本 |
| APG APi Group Corp | 2026-06-30 | 3/3 | $2.25B | $99M | $119M | 31.2% | 7.8% | 116 | 尚无授权文本 |
| APH AMPHENOL CORP /DE/ | 2026-06-30 | 3/3 | $8.76B | $1.77B | $2.03B | 40.5% | 29.5% | 98 | 尚无授权文本 |
| APPF APPFOLIO INC | 2026-06-30 | 3/3 | $281.12M | $41.54M | $121.67M | — | 18.8% | 77 | 尚无授权文本 |
| ATR APTARGROUP, INC. | 2026-06-30 | 3/3 | $1.03B | $87.57M | $99.22M | — | 12.3% | 71 | 尚无授权文本 |
| BCYC BICYCLE THERAPEUTICS PLC | 2026-06-30 | 3/3 | $629,000 | -$50.33M | -$116.51M | — | -8673.9% | 102 | 尚无授权文本 |
| CORT CORCEPT THERAPEUTICS INC | 2026-06-30 | 3/3 | $256.15M | $42.99M | $14.04M | 98.4% | 16.1% | 85 | 尚无授权文本 |
| CTNM Contineum Therapeutics, Inc. | 2026-06-30 | 3/3 | — | -$15.15M | -$28.09M | — | — | 35 | 尚无授权文本 |
| DX DYNEX CAPITAL INC | 2026-06-30 | 3/3 | — | $180.79M | — | — | — | 93 | 尚无授权文本 |
| DYN Dyne Therapeutics, Inc. | 2026-06-30 | 3/3 | — | -$178.56M | -$276.94M | — | — | 88 | 尚无授权文本 |
| FULC Fulcrum Therapeutics, Inc. | 2026-06-30 | 3/3 | — | -$26.18M | -$34.91M | — | — | 94 | 尚无授权文本 |
| HCXY Hercules Capital, Inc. | 2026-06-30 | 3/3 | — | $130.18M | — | — | — | 96 | 尚无授权文本 |
| HOWL Werewolf Therapeutics, Inc. | 2026-06-30 | 3/3 | — | $3.67M | — | — | — | 72 | 尚无授权文本 |
| HTGC Hercules Capital, Inc. | 2026-06-30 | 3/3 | — | $130.18M | — | — | — | 96 | 尚无授权文本 |
| KNSL Kinsale Capital Group, Inc. | 2026-06-30 | 3/3 | $548.52M | $175.87M | $480.44M | — | — | 76 | 尚无授权文本 |
| LADR Ladder Capital Corp | 2026-06-30 | 3/3 | — | $14.56M | — | — | — | 69 | 尚无授权文本 |
| LOAN MANHATTAN BRIDGE CAPITAL, INC | 2026-06-30 | 3/3 | $2.05M | $1.15M | — | — | 56.2% | 41 | 尚无授权文本 |
| NLY ANNALY CAPITAL MANAGEMENT INC | 2026-06-30 | 3/3 | — | $822.67M | — | — | — | 137 | 尚无授权文本 |
| OFS OFS Capital Corp | 2026-06-30 | 3/3 | — | $5.57M | — | — | — | 96 | 尚无授权文本 |
| OFSSH OFS Capital Corp | 2026-06-30 | 3/3 | — | $5.57M | — | — | — | 96 | 尚无授权文本 |
| OFSSO OFS Capital Corp | 2026-06-30 | 3/3 | — | $5.57M | — | — | — | 96 | 尚无授权文本 |
| ORC Orchid Island Capital, Inc. | 2026-06-30 | 3/3 | — | $89.19M | — | — | — | 135 | 尚无授权文本 |
| OWL BLUE OWL CAPITAL INC. | 2026-06-30 | 3/3 | $753.05M | $11.39M | $541.93M | — | — | 102 | 尚无授权文本 |
| PTCT PTC THERAPEUTICS, INC. | 2026-06-30 | 3/3 | $360.52M | $83.5M | $66.68M | — | 41.3% | 107 | 尚无授权文本 |
| QS QuantumScape Corp | 2026-06-30 | 3/3 | — | -$98.24M | -$130.86M | — | — | 115 | 尚无授权文本 |
| SMMT Summit Therapeutics Inc. | 2026-06-30 | 3/3 | — | -$215.7M | -$264.57M | — | — | 145 | 尚无授权文本 |
| TCBI TEXAS CAPITAL BANCSHARES INC/TX | 2026-06-30 | 3/3 | — | $84.95M | $179.67M | — | — | 77 | 尚无授权文本 |
| TCBIO TEXAS CAPITAL BANCSHARES INC/TX | 2026-06-30 | 3/3 | — | $84.95M | $179.67M | — | — | 77 | 尚无授权文本 |
| TENX TENAX THERAPEUTICS, INC. | 2026-06-30 | 3/3 | $0 | -$17.8M | — | — | — | 100 | 尚无授权文本 |
| VKTX Viking Therapeutics, Inc. | 2026-06-30 | 3/3 | $0 | -$128.02M | — | — | — | 70 | 尚无授权文本 |
| AAPL Apple Inc. | 2026-06-27 | 3/3 | $109.42B | $29.79B | $110.2B | 50.1% | 32.6% | 75 | 尚无授权文本 |
| APLD Applied Digital Corp. | 2026-05-31 | 3/3 | $611.31M | -$184.34M | — | 35.1% | -38.7% | 153 | 尚无授权文本 |
| NRIX Nurix Therapeutics, Inc. | 2026-05-31 | 3/3 | $9.04M | -$89.54M | -$171.47M | — | -1041.7% | 102 | 尚无授权文本 |
| PAPL Pineapple Financial Inc. | 2026-05-31 | 3/3 | $622,502 | $25.25M | -$4.62M | 50.5% | 4005.4% | 37 | 尚无授权文本 |
| TRAD APEX Tech Acquisition Inc. | 2026-05-31 | 3/3 | — | $68,355 | — | — | — | 6 | 尚无授权文本 |
| XFLH XFLH Capital Corp | 2026-05-31 | 3/3 | — | $757,749 | — | — | — | 5 | 尚无授权文本 |
| APOG APOGEE ENTERPRISES, INC. | 2026-05-30 | 3/3 | $342.68M | $11.54M | $1.14M | 21.9% | 5.5% | 88 | 尚无授权文本 |
| GAP GAP INC | 2026-05-02 | 3/3 | $3.5B | $339M | $78M | 40.5% | 12.7% | 81 | 尚无授权文本 |
| SAIC Science Applications International Corp | 2026-05-01 | 3/3 | $1.91B | $115M | $118M | 13.1% | 9.4% | 110 | 尚无授权文本 |
| BCTX BriaCell Therapeutics Corp. | 2026-04-30 | 3/3 | — | -$7.16M | -$22.82M | — | — | 133 | 尚无授权文本 |
| ENGN enGene Therapeutics Inc. | 2026-04-30 | 3/3 | — | -$30.23M | -$59.65M | — | — | 53 | 尚无授权文本 |
| GIII G III APPAREL GROUP LTD /DE/ | 2026-04-30 | 3/3 | — | $66.53M | — | — | — | 80 | 尚无授权文本 |
| VECA Vernal Capital Acquisition Corp. | 2026-04-30 | 3/3 | — | -$25,515 | — | — | — | 4 | 尚无授权文本 |
| AMAT APPLIED MATERIALS INC /DE | 2026-04-26 | 3/3 | $7.91B | $2.81B | $1.25B | 49.9% | 31.9% | 81 | 尚无授权文本 |
| AAP ADVANCE AUTO PARTS INC | 2026-04-25 | 3/3 | $2.61B | $24M | -$75M | 45.1% | 2.6% | 96 | 尚无授权文本 |
| NTAP NetApp, Inc. | 2026-04-24 | 3/3 | $6.93B | $1.28B | $1.87B | 70.7% | 24.2% | 70 | 尚无授权文本 |
| AACP Apogee Acquisition Corp | 2026-03-31 | 3/3 | — | -$55,000 | — | — | — | 4 | 尚无授权文本 |
| AAOI APPLIED OPTOELECTRONICS, INC. | 2026-03-31 | 3/3 | $151.14M | -$14.28M | -$143.58M | 29.1% | -8.6% | 120 | 尚无授权文本 |
| AARD Aardvark Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$21.59M | — | — | — | 26 | 尚无授权文本 |
| ABEO ABEONA THERAPEUTICS INC. | 2026-03-31 | 3/3 | $8.72M | -$17.08M | -$20.74M | 69.1% | -264.1% | 111 | 尚无授权文本 |
| ACAA Averin Capital Acquisition Corp. | 2026-03-31 | 3/3 | — | $832,500 | — | — | — | 6 | 尚无授权文本 |
| ACAAU Averin Capital Acquisition Corp. | 2026-03-31 | 3/3 | — | $832,500 | — | — | — | 6 | 尚无授权文本 |
| ACGL ARCH CAPITAL GROUP LTD. | 2026-03-31 | 3/3 | $4.52B | $1.05B | — | — | — | 113 | 尚无授权文本 |
| ACGLN ARCH CAPITAL GROUP LTD. | 2026-03-31 | 3/3 | $4.52B | $1.05B | — | — | — | 113 | 尚无授权文本 |
| ACGLO ARCH CAPITAL GROUP LTD. | 2026-03-31 | 3/3 | $4.52B | $1.05B | — | — | — | 113 | 尚无授权文本 |
| ACRS Aclaris Therapeutics, Inc. | 2026-03-31 | 3/3 | $2M | -$19.82M | -$18.16M | 80.2% | -1111.8% | 97 | 尚无授权文本 |
| ACRV Acrivon Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$19.04M | -$20.55M | — | — | 57 | 尚无授权文本 |
| ACTU ACTUATE THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$5.63M | — | — | — | 27 | 尚无授权文本 |
| ADCT ADC Therapeutics SA | 2026-03-31 | 3/3 | $20.03M | -$32.97M | -$29.74M | — | -126.0% | 167 | 尚无授权文本 |
| ADPT Adaptive Biotechnologies Corp | 2026-03-31 | 3/3 | $70.87M | -$20.03M | -$10.33M | 73.6% | -27.1% | 78 | 尚无授权文本 |
| AFCG Advanced Flower Capital Inc. | 2026-03-31 | 3/3 | — | $11.43M | — | — | — | 89 | 尚无授权文本 |
| AHCO AdaptHealth Corp. | 2026-03-31 | 3/3 | $819.8M | -$16.04M | -$27.49M | 13.6% | 0.7% | 106 | 尚无授权文本 |
| AIT APPLIED INDUSTRIAL TECHNOLOGIES INC | 2026-03-31 | 3/3 | $1.25B | $99.77M | — | 30.4% | 11.0% | 71 | 尚无授权文本 |
| AKBA Akebia Therapeutics, Inc. | 2026-03-31 | 3/3 | $53.54M | -$9.05M | -$21.27M | 77.0% | -8.8% | 128 | 尚无授权文本 |
| AKTX Akari Therapeutics Plc | 2026-03-31 | 3/3 | — | -$14.46M | — | — | — | 135 | 尚无授权文本 |
| ALDX Aldeyra Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$3.45M | — | — | — | 103 | 尚无授权文本 |
| ALGS Aligos Therapeutics, Inc. | 2026-03-31 | 3/3 | $2.83M | -$23.04M | — | — | -951.6% | 76 | 尚无授权文本 |
| ALLO Allogene Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$42.61M | -$12.92M | — | — | 88 | 尚无授权文本 |
| ALLR Allarity Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$2.75M | -$4.56M | — | — | 167 | 尚无授权文本 |
| ANAB ANAPTYSBIO, INC | 2026-03-31 | 3/3 | $25.56M | -$52.88M | -$25.94M | — | -135.5% | 103 | 尚无授权文本 |
| ANTX AN2 Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$10.03M | — | — | — | 56 | 尚无授权文本 |
| AP AMPCO PITTSBURGH CORP | 2026-03-31 | 3/3 | $103.13M | -$867,000 | -$1.74M | — | 2.5% | 75 | 尚无授权文本 |
| APA APA Corp | 2026-03-31 | 3/3 | — | $446M | — | — | — | 81 | 尚无授权文本 |
| APAC StoneBridge Acquisition II Corp | 2026-03-31 | 3/3 | — | $387,601 | — | — | — | 9 | 尚无授权文本 |
| APACU StoneBridge Acquisition II Corp | 2026-03-31 | 3/3 | — | $387,601 | — | — | — | 9 | 尚无授权文本 |
| APC ARKO Petroleum Corp. | 2026-03-31 | 3/3 | — | $8.08M | $713,000 | — | — | 8 | 尚无授权文本 |
| APEI AMERICAN PUBLIC EDUCATION INC | 2026-03-31 | 3/3 | $174.74M | $17.73M | $60.78M | 57.3% | 12.4% | 82 | 尚无授权文本 |
| APGE Apogee Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$74.11M | — | — | — | 49 | 尚无授权文本 |
| APLE Apple Hospitality REIT, Inc. | 2026-03-31 | 3/3 | $337.74M | $27.7M | — | 38.7% | 14.2% | 143 | 尚无授权文本 |
| APO Apollo Global Management, Inc. | 2026-03-31 | 3/3 | $5.06B | -$1.91B | — | — | — | 114 | 尚无授权文本 |
| APOS Apollo Global Management, Inc. | 2026-03-31 | 3/3 | $5.06B | -$1.91B | — | — | — | 114 | 尚无授权文本 |
| APP AppLovin Corp | 2026-03-31 | 3/3 | $1.84B | $1.21B | — | 88.9% | 78.2% | 76 | 尚无授权文本 |
| APPN APPIAN CORP | 2026-03-31 | 3/3 | $202.18M | -$1.53M | $48.64M | 73.1% | 1.6% | 77 | 尚无授权文本 |
| APPS Digital Turbine, Inc. | 2026-03-31 | 3/3 | $565.25M | -$37.73M | $11.19M | 56.9% | 6.0% | 84 | 尚无授权文本 |
| APRE Aprea Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$3.29M | — | — | — | 107 | 尚无授权文本 |
| APT ALPHA PRO TECH LTD | 2026-03-31 | 3/3 | — | $702,000 | -$105,000 | — | — | 57 | 尚无授权文本 |
| APTV Aptiv PLC | 2026-03-31 | 3/3 | $5.09B | $189M | — | 18.1% | 7.4% | 90 | 尚无授权文本 |
| APUR Aperture AC | 2026-03-31 | 3/3 | — | -$23,207 | — | — | — | 4 | 尚无授权文本 |
| APUS Apimeds Pharmaceuticals US, Inc. | 2026-03-31 | 3/3 | — | -$35.06M | -$2.08M | — | — | 24 | 尚无授权文本 |
| APVO Aptevo Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$6.7M | — | — | — | 135 | 尚无授权文本 |
| APXT Apex Treasury Corp | 2026-03-31 | 3/3 | — | $2.67M | — | — | — | 8 | 尚无授权文本 |
| APXTU Apex Treasury Corp | 2026-03-31 | 3/3 | — | $2.67M | — | — | — | 8 | 尚无授权文本 |
| APYX Apyx Medical Corp | 2026-03-31 | 3/3 | $12.49M | -$2.11M | -$632,000 | 63.5% | -7.3% | 90 | 尚无授权文本 |
| AQST Aquestive Therapeutics, Inc. | 2026-03-31 | 3/3 | $14.45M | -$8.06M | -$14.86M | 76.0% | -29.1% | 163 | 尚无授权文本 |
| ARCC ARES CAPITAL CORP | 2026-03-31 | 3/3 | — | $92M | — | — | — | 138 | 尚无授权文本 |
| ARCT Arcturus Therapeutics Holdings Inc. | 2026-03-31 | 3/3 | $2.06M | -$26.96M | -$19.44M | — | -1403.7% | 98 | 尚无授权文本 |
| ARI Apollo Commercial Real Estate Finance, Inc. | 2026-03-31 | 3/3 | $58.63M | $26.23M | — | — | — | 64 | 尚无授权文本 |
| ARQT Arcutis Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $105.4M | -$11.3M | $2.24M | 90.7% | -8.6% | 90 | 尚无授权文本 |
| ARTV Artiva Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$23.52M | -$21.19M | — | — | 27 | 尚无授权文本 |
| ATOS ATOSSA THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$9.59M | -$9.58M | — | — | 102 | 尚无授权文本 |
| ATPC Agape ATP Corp | 2026-03-31 | 3/3 | $273,658 | -$340,906 | — | 58.3% | -247.5% | 68 | 尚无授权文本 |
| ATRA Atara Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $516,000 | -$4.15M | — | — | -652.9% | 109 | 尚无授权文本 |
| AUTL Autolus Therapeutics plc | 2026-03-31 | 3/3 | $26.22M | -$71.6M | -$68.01M | 6.3% | -227.0% | 90 | 尚无授权文本 |
| AVTX Avalo Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$19.63M | — | — | — | 141 | 尚无授权文本 |
| AXS AXIS CAPITAL HOLDINGS LTD | 2026-03-31 | 3/3 | $1.64B | $254.77M | — | — | — | 119 | 尚无授权文本 |
| AXSM Axsome Therapeutics, Inc. | 2026-03-31 | 3/3 | $191.2M | -$64.54M | -$20.82M | — | -33.1% | 147 | 尚无授权文本 |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$42.11M | -$35.94M | — | — | 26 | 尚无授权文本 |
| BCAX Bicara Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$56.21M | -$37.57M | — | — | 25 | 尚无授权文本 |
| BCG Binah Capital Group, Inc. | 2026-03-31 | 3/3 | $47.07M | $1.9M | $527,000 | — | — | 26 | 尚无授权文本 |
| BCSF Bain Capital Specialty Finance, Inc. | 2026-03-31 | 3/3 | — | $3.39M | — | — | — | 118 | 尚无授权文本 |
| BCSS Bain Capital GSS Investment Corp. | 2026-03-31 | 3/3 | — | $4.01M | — | — | — | 8 | 尚无授权文本 |
| BDTX Black Diamond Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$9.04M | — | — | — | 81 | 尚无授权文本 |
| BEAM Beam Therapeutics Inc. | 2026-03-31 | 3/3 | $31.74M | -$94.32M | -$130.75M | — | -337.8% | 88 | 尚无授权文本 |
| BHFAP Brighthouse Financial, Inc. | 2026-03-31 | 3/3 | $1.53B | -$766M | — | — | — | 79 | 尚无授权文本 |
| BOLT Bolt Biotherapeutics, Inc. | 2026-03-31 | 3/3 | $26,000 | -$7.24M | — | — | -29234.6% | 65 | 尚无授权文本 |
| BRNS Barinthus Biotherapeutics plc. | 2026-03-31 | 3/3 | — | -$5.53M | -$3.37M | — | — | 74 | 尚无授权文本 |
| BRR ProCap Financial, Inc. | 2026-03-31 | 3/3 | $1,000 | -$107.76M | -$3.44M | — | -759800.0% | 15 | 尚无授权文本 |
| BRT BRT Apartments Corp. | 2026-03-31 | 3/3 | $24.61M | -$2.68M | — | — | -9.7% | 84 | 尚无授权文本 |
| BRTX BioRestorative Therapies, Inc. | 2026-03-31 | 3/3 | $23,170 | -$2.15M | — | 68.1% | -14612.6% | 74 | 尚无授权文本 |
| BTAI BioXcel Therapeutics, Inc. | 2026-03-31 | 3/3 | $206,000 | -$12.69M | -$11.81M | -37.4% | -4962.6% | 141 | 尚无授权文本 |
| BUR Burford Capital Ltd | 2026-03-31 | 3/3 | -$1.72B | -$1.63B | -$136.67M | — | 91.3% | 245 | 尚无授权文本 |
| CADL Candel Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$8.86M | -$18.71M | — | — | 102 | 尚无授权文本 |
| CAMP Camp4 Therapeutics Corp | 2026-03-31 | 3/3 | $1.29M | -$18.33M | -$10.98M | — | -1010.1% | 29 | 尚无授权文本 |
| CAPL CrossAmerica Partners LP | 2026-03-31 | 3/3 | — | $10.66M | $24.45M | — | — | 95 | 尚无授权文本 |
| CAPN Cayson Acquisition Corp | 2026-03-31 | 3/3 | — | $252,400 | — | — | — | 24 | 尚无授权文本 |
| CAPR CAPRICOR THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$33.94M | -$34.38M | — | — | 93 | 尚无授权文本 |
| CAPS Capstone Holding Corp. | 2026-03-31 | 3/3 | — | -$1.92M | -$2.82M | — | — | 31 | 尚无授权文本 |
| CART Maplebear Inc. | 2026-03-31 | 3/3 | $1.02B | $144M | $252M | 72.4% | 17.9% | 35 | 尚无授权文本 |
| CATX Perspective Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$26.19M | -$38.33M | — | — | 152 | 尚无授权文本 |
| CBNK Capital Bancorp Inc | 2026-03-31 | 3/3 | — | $12.02M | — | — | — | 109 | 尚无授权文本 |
| CCAP Crescent Capital BDC, Inc. | 2026-03-31 | 3/3 | — | -$15.51M | — | — | — | 84 | 尚无授权文本 |
| CCBG CAPITAL CITY BANK GROUP INC | 2026-03-31 | 3/3 | — | $15.82M | $14.66M | — | — | 92 | 尚无授权文本 |
| CCCC C4 Therapeutics, Inc. | 2026-03-31 | 3/3 | $6.15M | -$25.13M | -$30.01M | — | -451.6% | 96 | 尚无授权文本 |
| CCXI Churchill Capital Corp XI | 2026-03-31 | 3/3 | — | $3.17M | — | — | — | 9 | 尚无授权文本 |
| CCXIU Churchill Capital Corp XI | 2026-03-31 | 3/3 | — | $3.17M | — | — | — | 9 | 尚无授权文本 |
| CFFN Capitol Federal Financial, Inc. | 2026-03-31 | 3/3 | — | $20.15M | $35.98M | — | — | 77 | 尚无授权文本 |
| CGEM Cullinan Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$49.66M | — | — | — | 83 | 尚无授权文本 |
| CGTX COGNITION THERAPEUTICS INC | 2026-03-31 | 3/3 | — | -$4.57M | — | — | — | 89 | 尚无授权文本 |
| CLDI Calidi Biotherapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.11M | — | — | — | 120 | 尚无授权文本 |
| CLDX Celldex Therapeutics, Inc. | 2026-03-31 | 3/3 | $15,000 | -$78.69M | -$67.23M | — | -562900.0% | 71 | 尚无授权文本 |
| CLW Clearwater Paper Corp | 2026-03-31 | 3/3 | $360.3M | -$12.8M | -$8.6M | -0.2% | -2.9% | 74 | 尚无授权文本 |
| CMII Columbus Circle Capital Corp II | 2026-03-31 | 3/3 | — | $853,252 | — | — | — | 7 | 尚无授权文本 |
| CMPX Compass Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$18.32M | -$17.35M | — | — | 77 | 尚无授权文本 |
| CNTX Context Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$8.68M | -$11.47M | — | — | 71 | 尚无授权文本 |
| COAG Hemab Therapeutics Holdings, Inc. | 2026-03-31 | 3/3 | — | -$22.69M | -$21.7M | — | — | 4 | 尚无授权文本 |
| COF CAPITAL ONE FINANCIAL CORP | 2026-03-31 | 3/3 | $2.41B | $2.17B | $5.47B | — | — | 218 | 尚无授权文本 |
| COYA Coya Therapeutics, Inc. | 2026-03-31 | 3/3 | $251,147 | -$7.21M | — | — | -3042.1% | 64 | 尚无授权文本 |
| CPK CHESAPEAKE UTILITIES CORP | 2026-03-31 | 3/3 | $353.1M | $59.3M | -$23.9M | — | 28.2% | 113 | 尚无授权文本 |
| CRSP CRISPR Therapeutics AG | 2026-03-31 | 3/3 | $1.46M | -$122.93M | -$109.4M | — | -8933.3% | 94 | 尚无授权文本 |
| CSWC CAPITAL SOUTHWEST CORP | 2026-03-31 | 3/3 | — | $27.48M | -$193.79M | — | — | 124 | 尚无授权文本 |
| CTMX CytomX Therapeutics, Inc. | 2026-03-31 | 3/3 | $10.26M | -$18.25M | -$25.55M | — | -191.8% | 87 | 尚无授权文本 |
| CV CapsoVision, Inc | 2026-03-31 | 3/3 | $2.79M | -$7.03M | -$6.11M | 47.6% | -254.0% | 19 | 尚无授权文本 |
| CVKD Cadrenal Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$2.5M | — | — | — | 71 | 尚无授权文本 |
| CXAI CXApp Inc. | 2026-03-31 | 3/3 | $950,000 | -$4M | — | 83.2% | -434.1% | 72 | 尚无授权文本 |
| CXII Churchill Capital Corp XII | 2026-03-31 | 2/3 | — | -$44,797 | — | — | — | 5 | 尚无授权文本 |
| CXIIU Churchill Capital Corp XII | 2026-03-31 | 2/3 | — | -$44,797 | — | — | — | 5 | 尚无授权文本 |
| CYCN Cyclerion Therapeutics, Inc. | 2026-03-31 | 3/3 | $0 | -$3.18M | -$1.24M | — | — | 78 | 尚无授权文本 |
| DCOY Decoy Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$2.22M | — | — | — | 114 | 尚无授权文本 |
| DFTX Definium Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$77.1M | — | — | — | 138 | 尚无授权文本 |
| DMAC DiaMedica Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$10.04M | -$9.09M | — | — | 84 | 尚无授权文本 |
| DMRA Damora Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$27.78M | — | — | — | 63 | 尚无授权文本 |
| DNLI Denali Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$128.45M | -$133.67M | — | — | 97 | 尚无授权文本 |
| DNTH Dianthus Therapeutics, Inc. /DE/ | 2026-03-31 | 3/3 | — | -$40.83M | — | — | — | 89 | 尚无授权文本 |
| DRMA Dermata Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$1.85M | — | — | — | 94 | 尚无授权文本 |
| DSGN Design Therapeutics, Inc. | 2026-03-31 | 3/3 | $0 | -$17.64M | -$16.43M | — | — | 58 | 尚无授权文本 |
| DWTX Dogwood Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$4.99M | — | — | — | 93 | 尚无授权文本 |
| ECPG ENCORE CAPITAL GROUP INC | 2026-03-31 | 3/3 | $20.64M | $86.24M | $77.47M | — | 891.5% | 118 | 尚无授权文本 |
| EIKN Eikon Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$82.96M | -$90.06M | — | — | 7 | 尚无授权文本 |
| ELTX Elicio Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$11.82M | — | — | — | 99 | 尚无授权文本 |
| ELVN Enliven Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$23.63M | — | — | — | 75 | 尚无授权文本 |
| ERNA Ernexa Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$5.51M | -$2.27M | — | — | 135 | 尚无授权文本 |
| EWTX Edgewise Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$49.01M | -$42.8M | — | — | 69 | 尚无授权文本 |
| FATE FATE THERAPEUTICS INC | 2026-03-31 | 3/3 | $1.3M | -$31.21M | -$31.06M | — | -2540.4% | 81 | 尚无授权文本 |
| FCAP FIRST CAPITAL INC | 2026-03-31 | 3/3 | — | $4.33M | $5.85M | — | — | 68 | 尚无授权文本 |
| FDMT 4D Molecular Therapeutics, Inc. | 2026-03-31 | 3/3 | $3.05M | -$68.76M | — | — | -2416.1% | 86 | 尚无授权文本 |
| FHTX Foghorn Therapeutics Inc. | 2026-03-31 | 3/3 | $3.27M | -$19.88M | -$25.27M | — | -660.3% | 110 | 尚无授权文本 |
| FIGX FIGX Capital Acquisition Corp. | 2026-03-31 | 3/3 | — | $1.22M | — | — | — | 9 | 尚无授权文本 |
| FLNA FILANA THERAPEUTICS, INC. | 2026-03-31 | 3/3 | — | -$10.33M | — | — | — | 117 | 尚无授权文本 |
| FSK FS KKR Capital Corp | 2026-03-31 | 3/3 | — | -$441M | — | — | — | 169 | 尚无授权文本 |
| FSUN FIRSTSUN CAPITAL BANCORP | 2026-03-31 | 3/3 | — | $21.58M | -$14.12M | — | — | 74 | 尚无授权文本 |
| GALT GALECTIN THERAPEUTICS INC | 2026-03-31 | 3/3 | — | -$5.05M | — | — | — | 93 | 尚无授权文本 |
| GANX Gain Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$5.61M | — | — | — | 84 | 尚无授权文本 |
| GBDC GOLUB CAPITAL BDC, Inc. | 2026-03-31 | 3/3 | — | -$46.8M | — | — | — | 169 | 尚无授权文本 |
| GECC Great Elm Capital Corp. | 2026-03-31 | 3/3 | — | -$745,000 | — | — | — | 104 | 尚无授权文本 |
| GECCG Great Elm Capital Corp. | 2026-03-31 | 3/3 | — | -$745,000 | — | — | — | 104 | 尚无授权文本 |
| GECCH Great Elm Capital Corp. | 2026-03-31 | 3/3 | — | -$745,000 | — | — | — | 104 | 尚无授权文本 |
| GECCI Great Elm Capital Corp. | 2026-03-31 | 3/3 | — | -$745,000 | — | — | — | 104 | 尚无授权文本 |
| GIW GigCapital8 Corp. | 2026-03-31 | 3/3 | $0 | $1.94M | — | — | — | 7 | 尚无授权文本 |
| GIX GigCapital9 Corp. | 2026-03-31 | 3/3 | $0 | $1.25M | — | — | — | 6 | 尚无授权文本 |
| GLAD GLADSTONE CAPITAL CORP | 2026-03-31 | 3/3 | — | $15.46M | — | — | — | 110 | 尚无授权文本 |
| GLIBA Liberty Capital Corp/NV | 2026-03-31 | 3/3 | $256M | $18M | $22M | — | 11.7% | 29 | 尚无授权文本 |
| GLIBK Liberty Capital Corp/NV | 2026-03-31 | 3/3 | $256M | $18M | $22M | — | 11.7% | 29 | 尚无授权文本 |
| GLRE GREENLIGHT CAPITAL RE, LTD. | 2026-03-31 | 3/3 | $189.66M | $35.75M | — | — | — | 76 | 尚无授权文本 |
| GLUE Monte Rosa Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$44.5M | -$39.24M | — | — | 69 | 尚无授权文本 |
| GPCR Structure Therapeutics Inc. | 2026-03-31 | 3/3 | — | -$75.97M | $14.05M | — | — | 48 | 尚无授权文本 |
| GPK GRAPHIC PACKAGING HOLDING CO | 2026-03-31 | 3/3 | $2.15B | -$43M | — | 14.0% | 0.9% | 102 | 尚无授权文本 |
| GRCE Grace Therapeutics, Inc. | 2026-03-31 | 3/3 | — | -$7.79M | — | — | — | 109 | 尚无授权文本 |